PRAECIS PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: PRAECIS PHARMACEUTICALS INC, 10-Q, EX-10.9, 2000-11-13
Next: SILVERLEAF RESORTS INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CONTAINED IN THE COMPANY'S QUARTERLY
REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         146,378
<SECURITIES>                                         0
<RECEIVABLES>                                    2,148
<ALLOWANCES>                                         0
<INVENTORY>                                     29,957
<CURRENT-ASSETS>                               189,910
<PP&E>                                          55,095
<DEPRECIATION>                                   5,582
<TOTAL-ASSETS>                                 239,423
<CURRENT-LIABILITIES>                           51,376
<BONDS>                                         24,000
                                0
                                          0
<COMMON>                                           419
<OTHER-SE>                                     162,492
<TOTAL-LIABILITY-AND-EQUITY>                   239,423
<SALES>                                              0
<TOTAL-REVENUES>                                 7,334
<CGS>                                                0
<TOTAL-COSTS>                                   16,721
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 138
<INCOME-PRETAX>                                (7,132)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (7,132)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,132)
<EPS-BASIC>                                      (.17)
<EPS-DILUTED>                                    (.17)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission